ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Jord BioScience Secures Series B Funding to Revolutionize Microbial Solutions for Agriculture

--News Direct--

Jord BioScience, a leading science and analytics company providing customizable microbial solutions for agriculture, announced the closing of its Series B round. This funding round will accelerate Jord BioScience's development and commercialization of innovative microbial technologies to deliver next-generation crop inputs.

Lead investor Silver Blue LLC, a Maryland-based firm focusing on agrifoodtech, was joined by Discovery Capital Funding, a matching equity investment program for University of Minnesota, Minnesota’s Small Business Credit Initiative (SSBCI) Direct Investment, and existing investors.

“This funding round marks a significant milestone for Jord BioScience, validating our partnership approach and the true potential of our microbial solutions to transform agriculture,” said Dr. Keri Carstens, president and CEO, Jord BioScience. “With this investment, we're poised to scale our operations to help biologicals and crop inputs companies accelerate product discovery and innovation for farmers worldwide.”

Founded on over 30 years of deep microbial science for agriculture by Jord BioScience’s Chief Science Officer Dr. Linda Kinkel, the company currently is partnering with leading agribusinesses to fast-track biological solutions by leveraging its expansive microbial bank of more than 6,500 microbial isolates. Collected from diverse global soils, these isolates enhance, protect, or promote distinct modes of action in major crops, including corn, soybeans, canola, and wheat as well as some specialty crops.

The Jord Microbial Bank is a premier collection of more than 6,500 microbial isolates from agriculturally relevant ecosystems, spanning diverse geographies, habitats, and soil chemistries.

“While biological innovation continues to evolve, Jord BioScience stands out by offering a fast and cost-effective approach to product differentiation, life cycle management, and revenue generation for agricultural companies. We believe Jord's technology can bring improved consistency of performance to the biological industry at a time when farmers are under pressure to produce more food while navigating financial and environmental pressures," said Francis Goelet, director, Silver Blue LLC. "We look forward to seeing the positive impact of Jord BioScience as the company continues to grow."

For more information about Jord BioScience, visit jordbioscience.com.

About Jord BioScience:

Jord BioScience, founded on research from the University of Minnesota, is a science and analytics company developing cutting-edge microbial technologies to enhance crop productivity and sustainability in agriculture. The company leverages over three decades of research by Dr. Linda Kinkel and her team, who collected thousands of unique soil microbes globally. Jord's proprietary technology and custom formulations are designed to extend product lifecycles, enhance crop performance, and expand market adoption of microbial solutions. From product concept through commercialization, Jord BioScience fast-tracks novel product development, reducing discovery from years to less than 10 months. This approach maximizes value and results in today's competitive marketplace. The company is currently conducting product development trials in the U.S., Argentina, and Brazil. For more information, visit www.jordbioscience.com

Contact Details

AgTech PR for Jord BioScience

Jennifer Goldston

jennifer@agtechpr.com

Company Website

https://www.jordbioscience.com

View source version on newsdirect.com: https://newsdirect.com/news/jord-bioscience-secures-series-b-funding-to-revolutionize-microbial-solutions-for-agriculture-172538812

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.